Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease

Clinical Microbiology and Infection

Volumn 18, Issue 12, 2012, Pages

  Perez Romero, P ^a   Aydillo, T A ^a   Perez Ordonez A ^a   Munoz P ^b   Moreno, A ^c   Lopez Medrano F ^d   Bodro, M ^e   Montejo, M ^f   Gavalda J ^g   Carmen Farinas M ^h   Pachon, J ^a   Cordero, E ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f HOSPITAL DE CRUCES   (Spain)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Influenza immunization; Influenza infection; Pneumonia; Seasonal influenza vaccine; Solid organ transplantation

Indexed keywords

GRIPAVAC; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

AGED; ANTIBODY TITER; ARTICLE; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; SOLID ORGAN TRANSPLANT RECIPIENT;

EID: 84869117287     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12044     Document Type: Article

References (32)

1. Kumar D, Michaels MG, Morris MI et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10: 521-526.
2. Vilchez RA, McCurry K, Dauber J et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2: 287-291.
3. Klimov AI, Rocha E, Hayden FG, Shult PA, Roumillat LF, Cox NJ. Prolonged shedding of amantadine-resistant influenza A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis 1995; 172: 1352-1355.
4. Cordero E, Perez-Romero P, Moreno A et al. Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection. Clin Microbiol Infect 2012; 18: 67-73.
5. Hurst FP, Lee JJ, Jindal RM, Agodoa LY, Abbott KC. Outcomes associated with influenza vaccination in the first year after kidney transplantation. Clin J Am Soc Nephrol 2011; 6: 1192-1197.
6. Admon D, Engelhard D, Strauss N, Goldman N, Zakay-Rones Z. Antibody response to influenza immunization in patients after heart transplantation. Vaccine 1997; 15: 1518-1522.
7. Birdwell KA, Ikizler MR, Sannella EC et al. Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Am J Kidney Dis 2009; 54: 112-121.
8. Blumberg EA, Albano C, Pruett T et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996; 22: 295-302.
9. Burbach G, Bienzle U, Stark K et al. Influenza vaccination in liver transplant recipients. Transplantation 1999; 67: 753-755.
10. Candon S, Thervet E, Lebon P et al. Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant 2009; 9: 2346-2354.
11. Fraund S, Wagner D, Pethig K, Drescher J, Girgsdies OE, Haverich A. Influenza vaccination in heart transplant recipients. J Heart Lung Transplant 1999; 18: 220-225.
12. Gaeta GB, Pariani E, Amendola A et al. Influenza vaccination in patients with cirrhosis and in liver transplant recipients. Vaccine 2009; 27: 3373-3375.
13. Kimball P, Verbeke S, Flattery M, Rhodes C, Tolman D. Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients. Transplantation 2000; 69: 2449-2451.
14. Manuel O, Pascual M, Hoschler K et al. Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. Clin Infect Dis 2011; 52: 248-256.
15. Sanchez-Fructuoso AI, Prats D, Naranjo P et al. Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: Mycophenolate versus azathioprine. Transplantation 2000; 69: 436-439.
16. Scharpe J, Evenepoel P, Maes B et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008; 8: 332-337.
17. Nichol KL, Zimmerman R. Generalist and subspecialist physicians' knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: a nationwide survey. Arch Intern Med 2001; 161: 2702-2708.
18. + T cell responses to influenza vaccine. J Immunol 2004; 173: 673-681.
19. Schuurmans MM, Tini GM, Dalar L, Fretz G, Benden C, Boehler A. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort. J Heart Lung Transplant 2011; 30: 685-690.
20. Cordero E, Perez-Ordonez A, Aydillo TA et al. Therapy with m-Tor inhibitors decreases the response to the pandemic influenza A H1N1 vaccine in solid organ transplant recipients. Am J Transplant 2011; 11: 2205-2213.
21. Policy MoHaS. Prevención de la gripe. Recomendaciones de vacunación antigripal. Influenza prevention. Recommendations for influenza vaccination http://www.msps.es/ciudadanos/enfLesiones/enfTransmisibles/gripe/gripe.htm#prevencion
22. Lee N, Choi KW, Chan PK et al. Outcomes of adults hospitalised with severe influenza. Thorax 2010; 65: 510-515.
23. Louie JK, Acosta M, Samuel MC et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011; 52: 301-312.
24. Viasus D, Pano-Pardo JR, Pachon J et al. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection. Chest 2011; 140: 1025-1032.
25. Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 2000; 61: 85-93.
26. Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ. Immune response to influenza vaccine in adult liver transplant recipients. Liver Transpl 2001; 7: 311-313.
27. Manuel O, Humar A, Chen MH et al. Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients. Am J Transplant 2007; 7: 2567-2572.
28. Hedlund J, Christenson B, Lundbergh P, Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up. Vaccine 2003; 21: 3906-3911.
29. Vila-Corcoles A, Ochoa-Gondar O, Llor C, Hospital I, Rodriguez T, Gomez A. Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects. Eur Respir J 2005; 26: 1086-1091.
30. Mullooly JP, Bennett MD, Hornbrook MC et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121: 947-952.
31. Patriarca PA, Weber JA, Parker RA et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 1985; 253: 1136-1139.
32. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000; 160: 3243-3247.